PHAEurope Annual PH European Conference (APHEC) 2025 | Castelldefels, Barcelona – DAYS 2&3 | #APHEC2025
Busy days in Castelldefels for APHEC 2025! Over 75 delegates from 40 member associations across 35 countries joined pharma partners and expert speakers.⤵️
💙 PHAEurope proudly announces the launch of Heart Works – phaware®, a groundbreaking mobile app empowering people living with pulmonary hypertension (PH), now available globally! Developed by our partners at phaware® global association, this innovation arrives just in time...
Pulmonary hypertension (PH) is a life-threatening disease that silently damages the heart and lungs. Its symptoms often mimic milder conditions, delaying diagnosis and treatment—when time is everything. PH includes five types that cause high blood pressure in the lungs, ⤵️
#vai sul nostro sito https://t.co/lKXOyIJumU vi è un importante iniziativa
#aiutaci#puoi trovare anche sulla nostra pagina fb l'aiuto richiesto...un semplice sondaggio
#insieme si può
#vai sul nostro sito https://t.co/lKXOyIJumU vi è un importante iniziativa
#aiutaci#puoi trovare anche sulla nostra pagina fb l'aiuto richiesto...un semplice sondaggio
#insieme si può
PHAEUROPE remains committed to driving change for #pulmonaryhypertension patients. Together with our board, patient advocates, and experts, we actively engage in policy discussions across advisory boards, associations, and committees, bringing invaluable patient...⤵️
One of the exciting projects that I'm working on is something called the Bel Air Center. We hope to make this the leading virtual PH platform for pulmonary hypertension. Norwegian PH patient, Hall Skaara. @phaware podcast ep 498 @EuropePHA https://t.co/uWYnIdsyna